文献速递瓣膜病与结构性心脏病

识别经导管主动脉瓣置换术后再入院高风险患者

Identifying patients likely to be readmitted after transcatheter aortic valve replacement.
PubMed 文献 · Heart · 2019-10-24

本文综述了TAVR术后再入院的预测因素与原因。再入院率30天高达17.4%、1年达53.2%。非经股动脉入路、肾功能不全、慢性肺病、左室收缩功能不全、房颤、大出血及延长住院等预测再入院;新起搏器植入、瓣周主动脉瓣反流及三尖瓣反流严重程度为新预测因素。30天内再入院多因非心脏原因,但心脏原因(尤其心衰)再入院死亡风险更高。建议心脏团队常规评估再入院风险并采取整体预防措施。

要点

  • TAVR术后30天和1年再入院率分别高达17.4%和53.2%。
  • 非经股动脉入路、肾功能不全、慢性肺病、左室收缩功能不全、房颤、大出血及延长住院预测再入院。
  • 新起搏器植入、瓣周主动脉瓣反流及三尖瓣反流严重程度是新预测因素。

核心结论

  • 心脏团队应常规计算并考虑再入院风险,采取整体方法预防再入院。

主要发现

  • TAVR术后30天再入院率高达17.4%,1年达53.2%。
  • 30天内再入院更常见于非心脏病因,但心脏病因(尤其心衰)再入院者死亡风险高于非心脏病因。

临床怎么用

  • 熟悉最常见预测因素和原因,指导主动干预措施的制定。
  • 因多数再入院为非心脏原因,需采取更整体的预防策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hospital readmission following transcatheter aortic valve replacement (TAVR) contributes considerably to the costs of care. Readmission rates following TAVR have been reported to be as high as 17.4% at 30 days and 53.2% at 1 year. Patient and procedural factors predict an increased likelihood of readmission including non-transfemoral access, acute and chronic kidney impairment, chronic lung disease, left ventricular systolic dysfunction, atrial fibrillation, major bleeding and prolonged index hospitalisation. Recent studies have also found the requirement for new pacemaker implantation and the severity of paravalvular aortic regurgitation and tricuspid regurgitation to be novel predictors of readmission. Post-TAVR readmission within 30 days of discharge is more likely to occur for non-cardiac than cardiac pathology, although readmission for cardiac causes, especially heart failure, predicts higher mortality than readmission for non-cardiac causes. To combat the risk of readmission and associated mortality, the routine practice of calculating and considering readmission risk should be adopted by the heart team. Furthermore, because most readmissions following TAVR occur for non-cardiac reasons, more holistic approaches to readmission prevention are necessary. Familiarity with the most common predictors and causes of readmission should guide the development of initiatives to address these conditions proactively.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Goldsweig A, Aronow HD. Identifying patients likely to be readmitted after transcatheter aortic valve replacement. Heart. 2019. PMID: 31649048. doi:10.1136/heartjnl-2019-315381

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。